Nicotine and Chronic Kidney Disease
尼古丁与慢性肾脏病
基本信息
- 批准号:7524184
- 负责人:
- 金额:$ 56.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-20 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAngiotensin IIAnimal ModelAnimalsArtsAtherosclerosisBiological AssayBlood VesselsCell ProliferationChronic Kidney FailureClinicalClinical ResearchCollagen Type IVCyclinsDahl Hypertensive RatsDataDepositionDiabetes MellitusDialysis procedureEnd stage renal failureExtracellular MatrixExtracellular Matrix ProteinsFibronectinsGoalsGrowthHumanHypertensionImmunohistochemistryIn VitroIncidenceIndividualInjuryKidneyLung diseasesMediatingMediator of activation proteinModelingMolecular BiologyMolecular Biology TechniquesMorbidity - disease rateNational Health and Nutrition Examination SurveyNeuraxisNicotineOutcomePathogenesisPathway interactionsPatientsPlayPopulationPrevalencePreventiveProcessProductionPropertyProstaglandin-Endoperoxide SynthaseProstaglandinsProteinuriaPublic HealthPulmonary HypertensionReactive Oxygen SpeciesRenal glomerular diseaseResearchRiskRisk FactorsRoleSignal TransductionSmokeSmokerSourceTechniquesTestingTherapeuticTissuesTobaccoUnited StatesVascular EndotheliumVascular Smooth MuscleWorkbasecancer typecardiovascular risk factorcell growthcigarette smokingcigarette smokingcostcyclooxygenase 2diabeticexperiencehemodynamicsin vivolung vascular injurymesangial cellmortalitynon-diabeticnovel strategiespreventpublic health relevancereceptorresponsesalt sensitivevasculogenesis
项目摘要
DESCRIPTION (provided by applicant): Cigarette smoking has been identified as the most important cause of preventable morbidity and mortality in the U.S. Recent clinical studies suggest that in addition to being an important cardiovascular risk, cigarette smoking is also an important risk for the progression of chronic kidney disease (CKD) in diabetics, hypertensives and patients with glomerular diseases. The mechanisms by which cigarette smoking promotes the progression of chronic kidney disease have not been elucidated. Nicotine has been proposed as a compound in cigarette smoke that may play a role in the pathogenesis of vascular and lung injury in smokers. We herein hypothesize that nicotine, a stable product present in large amounts in cigarette smoke, accelerates the progression of CKD by promoting mesangial cell proliferation and extracellular matrix (ECM) deposition via specific nicotine receptors and resulting in the activation of pathways involved in cell growth and injury. We will test this hypothesis by pursuing the following specific Aim 1: To identify the role of nicotine exposure as a risk factor in the progression of chronic kidney disease. The hypothesis for this aim is that nicotine accelerates the progression of CKD in animal model of salt sensitive hypertension that is associated with renal injury by increasing the deposition of ECM proteins such as fibronectin and type IV collagen. We will also determine the role of nicotine induced hemodynamic changes on these effects and the distribution and expression of nicotine receptors in the kidneys of these animals. We will use a comprehensive approach utilizing several pharmacologic blockers to assess the effects of nicotine on renal injury in a well validated model of salt sensitive hypertension; Aim 2: To identify the role of ROS and COX-2 derived prostaglandins on the effects of nicotine in renal injury. The hypothesis for this aim that reactive oxygen species (ROS) and COX-2 derived prostaglandins are important mediators of the effects of nicotine induced renal injury in salt sensitive hypertension. These studies will be performed in Dahl salt sensitive rats and utilizing a combination of bioassays, molecular biology and immunohistochemistry techniques to assess the role of COX-2 derived prostaglandins and ROS on nicotine induced renal injury; Aim 3: To establish the signal transduction mechanisms mediating cell proliferation and ECM deposition in response to nicotine. The hypothesis for this aim is that nicotine activates several pathways involved in cell proliferation and matrix production including PKC activation, CREs, and Src/Raf-1/MAPK/cyclins. These studies will be performed in human mesangial cells utilizing a combination of state of the art molecular biology techniques. PUBLIC HEALTH RELEVANCE These studies will determine the role of nicotine as a risk factor in the progression of chronic kidney disease and will identify the mechanisms involved. These studies will unveil mechanisms that may explain the deleterious effects of cigarette smoking on renal injury. These studies will determine the role of nicotine, an important component of cigarette smoke, on kidney damage in an animal model of high blood pressure that is accompanied by kidney injury. We will use a variety of state of the art techniques to assess the mechanisms by which nicotine induces renal injury.
描述(由申请人提供):在美国,吸烟已被确定为可预防的发病率和死亡率的最重要原因。最近的临床研究表明,除了是重要的心血管风险外,吸烟也是糖尿病、高血压和肾小球疾病患者慢性肾脏疾病(CKD)进展的重要风险。吸烟促进慢性肾病进展的机制尚未阐明。尼古丁被认为是香烟烟雾中的一种化合物,可能在吸烟者血管和肺损伤的发病机制中发挥作用。我们在此假设,尼古丁是一种在香烟烟雾中大量存在的稳定产物,通过促进系膜细胞增殖和细胞外基质(ECM)沉积(通过特异性尼古丁受体)并导致细胞生长和损伤相关通路的激活,加速CKD的进展。我们将通过追求以下具体目标1来检验这一假设:确定尼古丁暴露作为慢性肾脏疾病进展的风险因素的作用。该目标的假设是,尼古丁通过增加ECM蛋白(如纤连蛋白和IV型胶原蛋白)的沉积,加速盐敏感性高血压动物模型中CKD的进展,该高血压与肾损伤相关。我们还将确定尼古丁诱导的血流动力学变化对这些效应的作用以及这些动物肾脏中尼古丁受体的分布和表达。我们将使用一种综合的方法,利用几种药理学阻断剂,以评估尼古丁对肾损伤的影响,在一个经过充分验证的模型盐敏感性高血压;目的2:确定活性氧和考克斯-2衍生的三尖杉酯碱的作用,尼古丁在肾损伤的影响。这一假说认为活性氧(ROS)和考克斯-2衍生的洋地黄素是盐敏感性高血压中尼古丁诱导的肾损伤效应的重要介质。这些研究将在Dahl盐敏感大鼠中进行,并利用生物测定、分子生物学和免疫组织化学技术的组合来评估考克斯-2衍生的洋地黄素和ROS在尼古丁诱导的肾损伤中的作用;目的3:建立响应于尼古丁介导细胞增殖和ECM沉积的信号转导机制。该目的的假设是尼古丁激活参与细胞增殖和基质产生的几种途径,包括PKC激活、克雷斯和Src/Raf-1/MAPK/细胞周期蛋白。这些研究将在人肾小球系膜细胞中进行,采用最先进的分子生物学技术。这些研究将确定尼古丁作为慢性肾脏疾病进展的风险因素的作用,并将确定相关机制。这些研究将揭示可能解释吸烟对肾损伤的有害影响的机制。这些研究将确定尼古丁(香烟烟雾的重要成分)在伴有肾损伤的高血压动物模型中对肾损伤的作用。我们将使用各种最先进的技术来评估尼古丁诱导肾损伤的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDGAR A JAIMES其他文献
EDGAR A JAIMES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDGAR A JAIMES', 18)}}的其他基金
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation
纳米技术作为动静脉瘘成熟的治疗方法
- 批准号:
10275814 - 财政年份:2021
- 资助金额:
$ 56.74万 - 项目类别:
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation
纳米技术作为动静脉瘘成熟的治疗方法
- 批准号:
10666430 - 财政年份:2021
- 资助金额:
$ 56.74万 - 项目类别:
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation
纳米技术作为动静脉瘘成熟的治疗方法
- 批准号:
10418812 - 财政年份:2021
- 资助金额:
$ 56.74万 - 项目类别:
ETS-1 and Vascular and Renal Injury in Salt Sensitive Hypertension
ETS-1 与盐敏感性高血压中的血管和肾脏损伤
- 批准号:
8391638 - 财政年份:2010
- 资助金额:
$ 56.74万 - 项目类别:
ETS-1 and Vascular and Renal Injury in Salt Sensitive Hypertension
ETS-1 与盐敏感性高血压中的血管和肾脏损伤
- 批准号:
8045940 - 财政年份:2010
- 资助金额:
$ 56.74万 - 项目类别:
ETS-1 and Vascular and Renal Injury in Salt Sensitive Hypertension
ETS-1 与盐敏感性高血压中的血管和肾脏损伤
- 批准号:
8198371 - 财政年份:2010
- 资助金额:
$ 56.74万 - 项目类别:
Glomerular COX-2 in Hypertensive Renal Disease
高血压肾病中的肾小球 COX-2
- 批准号:
7124216 - 财政年份:2005
- 资助金额:
$ 56.74万 - 项目类别:
Glomerular COX-2 in Hypertensive Renal Disease
高血压肾病中的肾小球 COX-2
- 批准号:
6984366 - 财政年份:2005
- 资助金额:
$ 56.74万 - 项目类别:
Glomerular COX-2 in Hypertensive Renal Disease
高血压肾病中的肾小球 COX-2
- 批准号:
7285217 - 财政年份:2005
- 资助金额:
$ 56.74万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 56.74万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 56.74万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 56.74万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 56.74万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 56.74万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 56.74万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 56.74万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 56.74万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 56.74万 - 项目类别:
Protection and organ injury by angiotensin II treatment for septic shock
血管紧张素II治疗感染性休克的保护作用和器官损伤
- 批准号:
20K09284 - 财政年份:2020
- 资助金额:
$ 56.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




